Ghent University Academic Bibliography

Advanced

Coagulation system activation and increase of D-dimers levels in peripheral arterial occlusive disease

Marc De Buyzere, Jan Philippé UGent, Daniel Duprez UGent, Gaston Baele and Denis Clement (1993) AMERICAN JOURNAL OF HEMATOLOGY. 43(2). p.91-94
abstract
The aim of the present study was to document coagulation system activation and basal fibrinolysis in peripheral arterial occlusive disease (PAOD) at stage II of Fontaine's classification. In 34 patients, prothrombin fragment (F1 + 2), thrombin-antithrombin III complexes (TAT), and D-dimer concentrations were evaluated before and after a standard treadmill test. Basal levels in PAOD of F1 + 2 (1.25 +/- 0.19 nmol/liter) and of TAT (3.34 +/- 0.35 mug/liter) were significantly increased compared to those obtained in age- and sex-matched healthy controls (0.68 +/- 0.06 nmol/liter and 2.30 +/- 0.33 mug/liter, respectively), showing baseline activation of the clotting cascade. A secondary activation of the fibrinolytic system was evidenced by the highly significant increase of basal D-dimers (719 +/- 99 ng/dl in PAOD vs. 229 +/- 37 ng/dl in controls). Treadmill exercise failed to increase the study parameters significantly further. Walking distance (583 +/- 40 m) was correlated with the preexercise ankle to brachial systolic blood pressure ratio (r = 0.485, P < 0.005) and inversely with the level of D-dimers (r = -0.425, P < 0.02). Under baseline conditions, the latter parameter was correlated as well with the antigen concentration of urokinase-type plasminogen activator (u-PA; r = 0.503, P < 0.002). These results indicate that stage II PAOD is characterized by an activation of the clotting cascade in baseline conditions evidenced by increased F1 + 2 and TAT. A secondary activation of the fibrinolytic system with increased u-PA antigen levels accounts for the elevated D-dimers. Treadmill exercise was unable to increase these parameters further.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
FIBRINOLYSIS, PAOD, CLOTTING SYSTEM, THROMBIN, TREADMILL EXERCISE, ANTITHROMBIN-III COMPLEX, FIBRIN DEGRADATION PRODUCTS, LINKED IMMUNOSORBENT-ASSAY, PLASMINOGEN-ACTIVATOR, INTERMITTENT CLAUDICATION, MONOCLONAL-ANTIBODIES, PULMONARY-EMBOLISM, VASCULAR-DISEASE, PLASMA, BLOOD
journal title
AMERICAN JOURNAL OF HEMATOLOGY
Am. J. Hematol.
volume
43
issue
2
pages
91 - 94
Web of Science type
Article
ISSN
0361-8609
DOI
10.1002/ajh.2830430204
language
English
UGent publication?
yes
classification
A1
id
201678
handle
http://hdl.handle.net/1854/LU-201678
date created
2004-01-14 13:42:00
date last changed
2017-10-23 08:43:50
@article{201678,
  abstract     = {The aim of the present study was to document coagulation system activation and basal fibrinolysis in peripheral arterial occlusive disease (PAOD) at stage II of Fontaine's classification. In 34 patients, prothrombin fragment (F1 + 2), thrombin-antithrombin III complexes (TAT), and D-dimer concentrations were evaluated before and after a standard treadmill test. Basal levels in PAOD of F1 + 2 (1.25 +/- 0.19 nmol/liter) and of TAT (3.34 +/- 0.35 mug/liter) were significantly increased compared to those obtained in age- and sex-matched healthy controls (0.68 +/- 0.06 nmol/liter and 2.30 +/- 0.33 mug/liter, respectively), showing baseline activation of the clotting cascade. A secondary activation of the fibrinolytic system was evidenced by the highly significant increase of basal D-dimers (719 +/- 99 ng/dl in PAOD vs. 229 +/- 37 ng/dl in controls). Treadmill exercise failed to increase the study parameters significantly further. Walking distance (583 +/- 40 m) was correlated with the preexercise ankle to brachial systolic blood pressure ratio (r = 0.485, P {\textlangle} 0.005) and inversely with the level of D-dimers (r = -0.425, P {\textlangle} 0.02). Under baseline conditions, the latter parameter was correlated as well with the antigen concentration of urokinase-type plasminogen activator (u-PA; r = 0.503, P {\textlangle} 0.002). These results indicate that stage II PAOD is characterized by an activation of the clotting cascade in baseline conditions evidenced by increased F1 + 2 and TAT. A secondary activation of the fibrinolytic system with increased u-PA antigen levels accounts for the elevated D-dimers. Treadmill exercise was unable to increase these parameters further.},
  author       = {De Buyzere, Marc and Philipp{\'e}, Jan and Duprez, Daniel and Baele, Gaston and Clement, Denis},
  issn         = {0361-8609},
  journal      = {AMERICAN JOURNAL OF HEMATOLOGY},
  keyword      = {FIBRINOLYSIS,PAOD,CLOTTING SYSTEM,THROMBIN,TREADMILL EXERCISE,ANTITHROMBIN-III COMPLEX,FIBRIN DEGRADATION PRODUCTS,LINKED IMMUNOSORBENT-ASSAY,PLASMINOGEN-ACTIVATOR,INTERMITTENT CLAUDICATION,MONOCLONAL-ANTIBODIES,PULMONARY-EMBOLISM,VASCULAR-DISEASE,PLASMA,BLOOD},
  language     = {eng},
  number       = {2},
  pages        = {91--94},
  title        = {Coagulation system activation and increase of D-dimers levels in peripheral arterial occlusive disease},
  url          = {http://dx.doi.org/10.1002/ajh.2830430204},
  volume       = {43},
  year         = {1993},
}

Chicago
DE BUYZERE, MARC, Jan Philippé, Daniel Duprez, Gaston Baele, and Denis Clement. 1993. “Coagulation System Activation and Increase of D-dimers Levels in Peripheral Arterial Occlusive Disease.” American Journal of Hematology 43 (2): 91–94.
APA
DE BUYZERE, M., Philippé, J., Duprez, D., Baele, G., & Clement, D. (1993). Coagulation system activation and increase of D-dimers levels in peripheral arterial occlusive disease. AMERICAN JOURNAL OF HEMATOLOGY, 43(2), 91–94.
Vancouver
1.
DE BUYZERE M, Philippé J, Duprez D, Baele G, Clement D. Coagulation system activation and increase of D-dimers levels in peripheral arterial occlusive disease. AMERICAN JOURNAL OF HEMATOLOGY. 1993;43(2):91–4.
MLA
DE BUYZERE, MARC, Jan Philippé, Daniel Duprez, et al. “Coagulation System Activation and Increase of D-dimers Levels in Peripheral Arterial Occlusive Disease.” AMERICAN JOURNAL OF HEMATOLOGY 43.2 (1993): 91–94. Print.